Insights - Page 51 of 107 - LucidQuest Ventures

Lucid Diligence Brief: Wa’ed Ventures Kure Cells pre-Series A

October 24, 2025venture capital,clinical trials,Regulatory,Cell Therapy,CAR T,biopharma,RMAT,Lucid Diligence Brief,payer access,diligence,Saudi Arabiamanufacturing

Lucid Diligence Brief: Wa’ed Ventures Kure Cells pre-Series A Professional…

by Timos Papagatsias

Public Health Today—October 24, 2025

October 24, 2025multiple sclerosis,semaglutide,immunotherapy,antimicrobial resistance,BioPharma and Tech News,Ischemic Stroke,Public Health News,mRNA COVID vaccines,Non-small cell lung cancerMetastatic melanoma,Periodontal disease

This week in public health features key biopharma moves driving care delivery…

by LucidQuest

Public Health Video Recap—October 24, 2025

October 24, 2025multiple sclerosis,CRISPR Therapeutics,Moderna,BioNTech,BioPharma and Tech News,Novo Nordisk,melanoma,Public Health News,mRNA COVID vaccinesADA-SCID,amyotrophic lateral sclerosis

Join us for this biweekly roundup of Public Health news, where we summarize…

by LucidQuest

Respiratory Today—October 24, 2025

October 24, 2025IPF,gsk,pfizer,sanofi,RSV,COPD,BioPharma and Tech News,Tezspire,Respiratory News,American Lung AssociationDupixent,JASCAYD

Catch the latest respiratory news, featuring industry updates, clinical…

by LucidQuest

Vaccines Today—October 24, 2025

October 24, 2025sanofi,RSV,Moderna,BioNTech,BioPharma and Tech News,IO Biotech,Vaccine news,Efluelda,CSL Seqirus,American Lung AssociationShingrix,influenza

This week’s vaccine news delivers the latest updates, research developments,…

by LucidQuest

Lucid Diligence Brief: Electra Therapeutics $183M Series C

October 24, 2025venture capital,clinical trials,Regulatory,hematology,immunology,rare disease,biopharma,Lucid Diligence Brief,payer access,diligencesHLH

Lucid Diligence Brief: Electra Therapeutics $183M Series C Professional…

by Timos Papagatsias

Cardiovascular Video Recap—October 23, 2025

October 23, 2025BioPharma and Tech News,pulmonary embolismCardiovascular News,Milestone Pharmaceuticals,Jupiter Endovascular,etripamil,PSVT,Artivion,aortic dissection,Vasa Therapeutics

This biweekly video brings you key highlights from across the cardiovascular…

by LucidQuest

Lucid Diligence Brief: Takeda and Innovent global oncology partnership

October 23, 2025Oncology,clinical trials,market access,Regulatory,biopharma,immuno-oncology,Lucid Diligence Brief,payer access,diligence,antibody-drug conjugatespartnerships

Lucid Diligence Brief: Takeda and Innovent global oncology partnership…

by Timos Papagatsias

Rare Disease Video Recap—October 23rd 2025

October 23, 2025sanofi,BioPharma and Tech News,ITP,Ipsen,Rocket Pharmaceuticals,Rare Disease News,Kresladi,Abeona Therapeutics,ChiesiXLRS,Wayrilz

In this biweekly edition, we cover the most significant developments shaping…

by LucidQuest

Cardiovascular Today—October 23, 2025

October 23, 2025BioPharma and Tech News,T2DHEART FAILURE,Stroke Prevention,type 2 diabetes,Atrial fibrillation,Cardiovascular Risk,CABG,Cardiovascular News,Healthium Medtech,Hello Heart

Get the latest on Cardiovascular this week, including key industry…

by LucidQuest

Rare Disease Today—October 23, 2025

October 23, 2025sanofi,BioPharma and Tech News,Netherton syndrome,Myelodysplastic Syndrome,Stargardt,AAVantgarde Bio,Rare Disease News,Kiniksa,pericarditisQuoin,Minovia

This week’s rare disease news delivers the latest regulatory updates, and…

by LucidQuest

Cell and Gene Therapy Today—October 23, 2025

October 23, 2025astellas,BioPharma and Tech News,HEART FAILURE,Friedreich ataxia,Biogen,AskBio,Lexeo Therapeutics,Cell and Gene Therapy News,cardiomyopathySkyclaris,Neuromuscular disorders

This week’s Cell and Gene Therapy update spotlights key developments,…

by LucidQuest

Minimize Uncertainty – Make Informed Decisions – Succeed